ClinicalTrials.Veeva

Menu

The Norwegian Adult Achondroplasia Study

S

Sunnaas Rehabilitation Hospital

Status

Completed

Conditions

Achondroplasia

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT03780153
2019/FO249324

Details and patient eligibility

About

The study aims to investigate the Norwegian adult achondroplasia population regarding degree and extent of symptoms and clinical manifestations and how this population manages in daily life, including demographics, physical function, and work participation.

Full description

The present study aims to investigate the degree and extent of spinal stenosis, chronic pain, sleep apnoea, impaired hearing, cardiovascular risk factors and body composition in Norwegian adults with achondroplasia. The study will also explore these factors' impact on physical function, ability to perform daily activities, work participation and needs for assistive devices and social benefits. The study is conducted in collaboration with the Norwegian Restricted Growth Association, and TRS National Resource Centre for Rare Disorders, Sunnaas Rehabilitation Hospital, Lovisenberg Hospital and Oslo University Hospital.

Enrollment

50 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Residents of Norway
  • Aged 16 years or older
  • Clinical and genetic diagnosis of achondroplasia
  • Speak and understand the Norwegian language.

Exclusion criteria

  • Severe cognitive deficits, mental illness or substance abuse
  • Having a medical condition making them unable to participate in the study.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems